Role of 2′-2′ difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas

Radiotherapy and Oncology

Volumn 70, Issue 1, 2004, Pages 55-61

  Rosier, Jean François ^a,b   Bruniaux, Monique ^a   Husson, Bernard ^a   Octave Prignot, Michelle ^b   Beauduin, Marc ^a   Grégoire, Vincent ^b  

^a CH Jolimont Lobbes   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Cell cycle; Gemcitabine; Human head and neck squamous carcinoma cells; Radio enhancement

Indexed keywords

BROXURIDINE; GEMCITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; RADIOSENSITIZING AGENT;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL KINETICS; CELL SYNCHRONIZATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; DRUG EFFECT; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; INCUBATION TIME; IONIZING RADIATION; MITOSIS INHIBITION; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TEMPERATURE; CELL CULTURE; CELL CYCLE; HEAD AND NECK TUMOR; PATHOLOGY;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE; DEOXYCYTIDINE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0842281708     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.10.006     Document Type: Article

References (32)

1. Biade S., Stobbe C.C., Chapman J.D. The intrinsic radiosensitivity of some human tumor cells throughout their cell cycles. Radiat Res. 147:1997;416-421.
2. Bristow R.G., Benchimol S., Hill R.P. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol. 40:1996;197-223.
3. Davis M., Tang H.Y., Maybaum J., Lawrence T. Dependence of fluorodeoxyuridine-mediated radiosensitization on S phase progression. Int J Radiat Biol. 67:1995;509-512.
4. Gandhi V., Legha J., Chen F., Hertel L.W., Plunkett W. Excision of 2′-2′ difluorodeoxycytidine (gemcitabine) monophosphate residues from DNA. Cancer Res. 56:1996;4453-4459.
5. Garrett C., Santi D. A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal Biochem. 99:1979;268-273.
6. Gregoire V., Beauduin M., Bruniaux M., Decoster B., Octave M., Scalliet P. Radiosensitization of mouse sarcoma cells by fludarabine or gemcitabine, two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by PFGE. Int J Radiat Biol. 73:1998;511-520.
7. Gregoire V., Hittelman W.N., Rosier J.F., Milas L. Chemo-radiotherapy: radiosensitizing nucleotide analogues. Oncol Rep. 6:1999;949-957.
8. Gregoire V., Nguyen T.V., Stephens L.C., et al. The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. Cancer Res. 54:1994;6201-6209.
9. Hall E.J. Radiosensitivity and cell age in the mitotic cycle. Hall E.J. Radiobiology for the radiologist. 1994;97-98 JB Lippincott, Philadelphia, PA.
10. Heineman V., Xu Y., Chubb S., et al. Cellular elimination of 2′-2′ difluorodeoxycytidine 5′ triphosphate: a mechanism of self-potentiation. Cancer Res. 52:1992;533-539.
11. Huang N.J., Hittelman W.N. Transcient inhibition of chromosome damage repair after ionizing radiation by gemcitabine. Proc Am Assoc Cancer Res. 36:1995;612.
12. Iliakis G. The role of DNA strand breaks in ionizing radiation-induced killing of eukaryotic cells. Bioessays. 13:1991;641-648.
13. Ishioka C., Frebourg T., Yan Y.X., et al. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet. 5:1993;124-129.
14. Joschko M., Webster L.K., Groves J., et al. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model. Radiat Oncol Invest. 5:1997;62-71.
15. Latz D., Fleckenstein K., Eble M., Blatter J., Wannenmacher M., Weber K.J. Radiosensitizing potential of gemcitabine within the cell cycle in vitro. Int J Radiat Oncol Biol Phys. 41:1998;875-882.
16. Lawrence T.S., Chang E., Hahn T.M., Hertel L.W., Shewach D.S. Radiosensitization of pancreatic cancer cells by 2′-2′ difluoro-2′ deoxycytidine. Int J Radiat Oncol Biol Phys. 41:1996;867-872.
17. Lawrence T.S., Davis M.A., Loney T.L. Fluoropyrimidine-mediated radiosensitization depends on cyclin E dependent kinase activation. Cancer Res. 56:1996;3203-3206.
18. Maity A., McKenna W.G., Muschel R.J. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol. 31:1994;1-13.
19. Manhardt E., Huang P., Plunkett W. Gemcitabine incorporation induces an upregulation of p21 in the human AML cell line. Proc Am Assoc Cancer Res. 38:1997;4048.
20. Nagasawa H., Keng P., Maki C., Yu Y., Little J.B. Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection. Cancer Res. 58:1998;2036-2041.
21. Peters G.J., Ackland S.P. New antimetabolites in preclinical and clinical development. Expert Opin Investig Drugs. 5:1996;637-679.
22. Pollack A., Terry N.H., Van N.T., Meistrich M.L. Flow cytometry analysis of two incorporated halogenated thymidine analogues and DNA in a mouse mammary tumor grown in vivo. Cytometry. 14:1993;168-172.
23. Plunkett W., Huang P., Xu Y.Z., Heineman V., Grunewald R., Gandhi V. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol. 22:1995;3-10.
24. Rosier J.F., Beauduin M., Bruniaux M., et al. The effect of gemcitabine on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity. Int J Radiat Biol. 75:1999;245-251.
25. Rosier J.F., Michaux L., Ameye G., et al. The radioenhancement of two head and neck squamous cell carcinomas by 2′-2′ difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs. Mutat Res. 527:2003;15-26.
26. Ruiz van Haperen V., Veerman G., Vermorken J.B., Peters G.J. Regulation of phosphorylation of deoxycytidine and 2′-2′ difluorodeoxycytidine; effects of cytidine 5′-triphosphate and uridine 5′-triphosphate in relation to chemosensitivity for 2′-2′ difluorodeoxycytidine. Biochem Pharmacol. 51:1996;911-918.
27. Schwartz J.L., Rotmensch J., Giovanazzi S.M., Cohen M.B., Weichselbaum R.R. Faster repair of DNA double strand breaks in radioresistant human tumor cells. Int J Radiat Oncol Biol Phys. 15:1988;907-912.
28. Shewach D.S., Lawrence T.S. Radiosensitization of human cells by gemcitabine in vitro. Semin Oncol. 22:(S11):1995;68-71.
29. Shewach D.S., Hahn T.M., Chang E., Hertel H.W., Lawrence T.S. Metabolism of for 2′-2′ difluorodeoxycytidine and radiosensitization of human colon carcinoma cells. Cancer Res. 54:1994;3218-3223.
30. Soussi T. The p53 tumour suppressor gene: from molecular biology to clinical investigation. Klijn J.G.M. Prognostic and predictive value of p53. 1997;3-21 Elsevier, Amsterdam.
31. Smeets M.F., Mooren E.H., Abdel-Wahab A.H., Bartelink H., Begg A.C. Differential repair of radiation induced DNA damage in human squamous carcinoma cells and the effect of caffeine and cysteamine on DNA double strand break induction and repair. Radiat Res. 140:1994;153-160.
32. Traut T.W. Enzymes of the nucleotide metabolism/significance of subunit size and polymer size for biological function and regulatory properties. Crit Rev Biochem. 23:1988;121-169.